• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速合成含有疏水性无机纳米颗粒的脂质纳米颗粒。

Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles.

机构信息

Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, V6T1Z3, Canada.

出版信息

Nanoscale. 2017 Sep 21;9(36):13600-13609. doi: 10.1039/c7nr03272b.

DOI:10.1039/c7nr03272b
PMID:28876010
Abstract

A straightforward "bottom-up" synthesis is described for efficient entrapment of inorganic hydrophobic nanoparticles (HNPs) consisting of iron oxide, gold, or quantum dots within the hydrophobic core of lipid nanoparticles (LNPs). These LNPs consist of hydrophobic "core" lipids such as triolein surrounded by a monolayer of amphipathic "surface" lipids, such as phosphatidylcholine and polyethylene-glycol-lipid. It is shown that rapid, controlled mixing of HNPs, core lipids and surface lipids in an organic solvent with an aqueous phase resulted in stable, monodisperse LNPs containing HNPs (LNP-HNP). This method allows 40-fold more hydrophobic iron oxide nanoparticles (IONPs) to be entrapped within an LNP than previous methods and can be readily extended to encapsulate other HNPs. The LNP-HNP diameter can be modulated over the range of 35-150 nm by varying the flow rate during particle synthesis or by varying the core-to-surface lipid ratio. LNP-IONPs can be generated using a variety of "core" lipids, including other triglycerides as well as cholesteryl-palmitate and tocopherol. Finally, it is shown that LNP-IONPs are accumulated in the liver, resulting in enhanced contrast for in vivo MRI. It is concluded that the bottom-up approach for encapsulating HNPs within LNPs has advantages of homogeneity, reproducibility and stability required for biomedical applications.

摘要

一种直接的“自下而上”的合成方法被描述为高效地将无机疏水性纳米粒子(HNPs)包埋在脂质纳米粒子(LNPs)的疏水性核心内,这些 HNPs 由氧化铁、金或量子点组成。这些 LNPs 由疏水性“核心”脂质(如三油酸甘油酯)组成,周围是一层两亲性“表面”脂质,如磷脂酰胆碱和聚乙二醇脂质。研究表明,将 HNPs、核心脂质和表面脂质在有机溶剂中与水相快速、可控地混合,可得到稳定的单分散 LNPs,其中包含 HNPs(LNP-HNP)。与以前的方法相比,该方法可将多达 40 倍的疏水性氧化铁纳米粒子(IONPs)包埋在 LNP 中,并且可以很容易地扩展到封装其他 HNPs。通过改变粒子合成过程中的流速或改变核-壳脂质比,可以将 LNP-HNP 的直径调节在 35-150nm 的范围内。LNP-IONPs 可以使用各种“核心”脂质生成,包括其他三酸甘油酯以及胆固醇棕榈酸酯和生育酚。最后,研究表明 LNP-IONPs 在肝脏中积累,从而增强了体内 MRI 的对比。结论是,将 HNPs 包埋在 LNPs 中的自下而上的方法具有生物医学应用所需的均一性、重现性和稳定性优势。

相似文献

1
Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles.快速合成含有疏水性无机纳米颗粒的脂质纳米颗粒。
Nanoscale. 2017 Sep 21;9(36):13600-13609. doi: 10.1039/c7nr03272b.
2
Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing.采用毫秒级微流控混合技术,从下至上设计并合成具有水性和甘油三酯核的极限尺寸脂质纳米颗粒体系。
Langmuir. 2012 Feb 21;28(7):3633-40. doi: 10.1021/la204833h. Epub 2012 Feb 9.
3
Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with Co-porphyrin: Oleylamine ensures stable chelation of cobalt in nanoparticles that accumulate in tumors.钴卟啉标记的疏水性纳米颗粒的螯合、制剂、包封、保留和体内生物分布:油胺确保了纳米颗粒中钴的稳定螯合,从而使纳米颗粒在肿瘤中积累。
J Control Release. 2018 Dec 10;291:11-25. doi: 10.1016/j.jconrel.2018.09.027. Epub 2018 Oct 3.
4
Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.采用实验设计方法对含可离子化阳离子脂质的脂质纳米粒子进行表征。
Langmuir. 2021 Jan 26;37(3):1120-1128. doi: 10.1021/acs.langmuir.0c03039. Epub 2021 Jan 13.
5
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.辅助脂质在用于寡核苷酸递送的脂质纳米颗粒(LNP)中的作用。
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):129-137. doi: 10.1016/j.addr.2016.01.022. Epub 2016 Feb 18.
6
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.采用微流控混合平台制备和表征用于基因传递的脂质纳米粒。
J Vis Exp. 2021 Feb 25(168). doi: 10.3791/62226.
7
Synthesis and Characterization of Hybrid Lipid Nanoparticles Containing Gold Nanoparticles and a Weak Base Drug.载金混合脂质纳米粒子的合成与表征。
Langmuir. 2022 Jun 28;38(25):7858-7866. doi: 10.1021/acs.langmuir.2c01221. Epub 2022 Jun 16.
8
Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.理解具有混沌微混合器的微流控装置中脂质纳米颗粒的形成机制。
PLoS One. 2017 Nov 28;12(11):e0187962. doi: 10.1371/journal.pone.0187962. eCollection 2017.
9
Encapsulation and retention of chelated-copper inside hydrophobic nanoparticles: Liquid cored nanoparticles show better retention than a solid core formulation.螯合铜在疏水性纳米颗粒中的包封与保留:液芯纳米颗粒比实心核制剂表现出更好的保留效果。
Eur J Pharm Biopharm. 2016 May;102:64-76. doi: 10.1016/j.ejpb.2016.02.015. Epub 2016 Feb 27.
10
Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.用于全身递送siRNA治疗剂的低分子量氨基脂质纳米颗粒中奥斯特瓦尔德熟化的稳定化。
Mol Pharm. 2014 Nov 3;11(11):4143-53. doi: 10.1021/mp500367k. Epub 2014 Oct 15.

引用本文的文献

1
Standardizing a Protocol for Streamlined Synthesis and Characterization of Lipid Nanoparticles to Enable Preclinical Research and Education.标准化脂质纳米颗粒简化合成与表征方案以推动临床前研究与教育
bioRxiv. 2025 Aug 1:2025.07.31.667476. doi: 10.1101/2025.07.31.667476.
2
Controlling Payload Heterogeneity in Lipid Nanoparticles for RNA-Based Therapeutics.控制用于基于RNA的疗法的脂质纳米颗粒中的载药异质性。
bioRxiv. 2025 Jun 11:2025.06.11.659145. doi: 10.1101/2025.06.11.659145.
3
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery.
用于RNA递送的脂质纳米颗粒制剂与制备的综合分析。
Int J Pharm X. 2024 Sep 10;8:100283. doi: 10.1016/j.ijpx.2024.100283. eCollection 2024 Dec.
4
Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.闪式纳米沉淀辅助可离子化脂质纳米粒自组装用于核酸递送。
Nanoscale. 2024 Apr 4;16(14):6939-6948. doi: 10.1039/d4nr00278d.
5
Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics.利用微流控技术实现药物和生物制剂的纳米颗粒制剂的先进制造。
Analyst. 2024 Jan 29;149(3):614-637. doi: 10.1039/d3an01739g.
6
Strategies for targeted gene delivery using lipid nanoparticles and cell-derived nanovesicles.使用脂质纳米颗粒和细胞衍生纳米囊泡进行靶向基因递送的策略。
Nanoscale Adv. 2023 Jul 7;5(15):3834-3856. doi: 10.1039/d3na00198a. eCollection 2023 Jul 25.
7
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of imaging.用于 RNA 治疗药物递送的脂质纳米颗粒:现状和成像的作用。
Theranostics. 2022 Oct 24;12(17):7509-7531. doi: 10.7150/thno.77259. eCollection 2022.
8
Lipid-based nucleic acid therapeutics with in vivo efficacy.具有体内疗效的基于脂质的核酸治疗药物。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1856. doi: 10.1002/wnan.1856. Epub 2022 Sep 30.
9
Processing Parameters and Ion Excipients Affect the Physicochemical Characteristics of the Stereocomplex-Formed Polylactide-b-Polyethylene Glycol Nanoparticles and Their Pharmacokinetics.加工参数和离子辅料影响立体复合形成的聚丙交酯-聚乙二醇纳米颗粒的物理化学特性及其药代动力学。
Pharmaceutics. 2022 Mar 4;14(3):568. doi: 10.3390/pharmaceutics14030568.
10
Microfluidic formulation of nanoparticles for biomedical applications.用于生物医学应用的纳米颗粒的微流体制备。
Biomaterials. 2021 Jul;274:120826. doi: 10.1016/j.biomaterials.2021.120826. Epub 2021 Apr 26.